693 related articles for article (PubMed ID: 33945793)
1. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance.
Wang C; Li Y; Jia L; Kim JK; Li J; Deng P; Zhang W; Krebsbach PH; Wang CY
Cell Stem Cell; 2021 Sep; 28(9):1597-1613.e7. PubMed ID: 33945793
[TBL] [Abstract][Full Text] [Related]
2. Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing.
Xiao M; Zhang X; Zhang D; Deng S; Zheng A; Du F; Shen J; Yue L; Yi T; Xiao Z; Zhao Y
Front Immunol; 2022; 13():1050951. PubMed ID: 36451812
[TBL] [Abstract][Full Text] [Related]
3. Targeting BMI1
Chen D; Wu M; Li Y; Chang I; Yuan Q; Ekimyan-Salvo M; Deng P; Yu B; Yu Y; Dong J; Szymanski JM; Ramadoss S; Li J; Wang CY
Cell Stem Cell; 2017 May; 20(5):621-634.e6. PubMed ID: 28285905
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells.
Qian X; Nie X; Wollenberg B; Sudhoff H; Kaufmann AM; Albers AE
Adv Exp Med Biol; 2019; 1139():23-40. PubMed ID: 31134493
[TBL] [Abstract][Full Text] [Related]
5. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma.
Borgmann M; Oetting A; Meyer F; Möckelmann N; Droste C; von Bargen CM; Möller-Koop C; Witt M; Borgmann K; Rothkamm K; Betz C; Münscher A; Clauditz TS; Rieckmann T
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3383-3393. PubMed ID: 35941227
[TBL] [Abstract][Full Text] [Related]
8. PVT1 inhibition stimulates anti-tumor immunity, prevents metastasis, and depletes cancer stem cells in squamous cell carcinoma.
Qin Z; Zhang W; Liu S; Wang Y; Peng X; Jia L
Cell Death Dis; 2023 Mar; 14(3):187. PubMed ID: 36894542
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
10. BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse.
Jia L; Zhang W; Wang CY
Cell Stem Cell; 2020 Aug; 27(2):238-253.e6. PubMed ID: 32697949
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma.
Dong J; Li J; Li Y; Ma Z; Yu Y; Wang CY
Nat Commun; 2021 Jun; 12(1):3974. PubMed ID: 34172737
[TBL] [Abstract][Full Text] [Related]
12. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
13. Biology and immunology of cancer stem(-like) cells in head and neck cancer.
Qian X; Ma C; Nie X; Lu J; Lenarz M; Kaufmann AM; Albers AE
Crit Rev Oncol Hematol; 2015 Sep; 95(3):337-45. PubMed ID: 25907739
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of immune evasion by head and neck cancer stem cells.
Xavier FCA; Silva JC; Rodini CO; Rodrigues MFSD
Front Oral Health; 2022; 3():957310. PubMed ID: 35982868
[TBL] [Abstract][Full Text] [Related]
15. CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs.
Xiong G; Chen Z; Liu Q; Peng F; Zhang C; Cheng M; Ling R; Chen S; Liang Y; Chen D; Zhou Q
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724465
[TBL] [Abstract][Full Text] [Related]
16. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
[TBL] [Abstract][Full Text] [Related]
18. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
19. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
Li Z; Wu X; Li J; Yu S; Ke X; Yan T; Zhu Y; Cheng J; Yang J
Exp Cell Res; 2022 Sep; 418(1):113271. PubMed ID: 35764101
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
